These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 12529357)

  • 21. A competitive chromogenic assay to study the functional interaction of urokinase-type plasminogen activator with its receptor.
    Rettenberger P; Wilhelm O; Oi H; Weidle UH; Goretzki L; Koppitz M; Lottspeich F; König B; Pessara U; Kramer MD
    Biol Chem Hoppe Seyler; 1995 Oct; 376(10):587-94. PubMed ID: 8590627
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potential role of kringle-integrin interaction in plasmin and uPA actions (a hypothesis).
    Takada Y
    J Biomed Biotechnol; 2012; 2012():136302. PubMed ID: 23125522
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selective inhibition by kringle 5 of human plasminogen on endothelial cell migration, an important process in angiogenesis.
    Ji WR; Barrientos LG; Llinás M; Gray H; Villarreal X; DeFord ME; Castellino FJ; Kramer RA; Trail PA
    Biochem Biophys Res Commun; 1998 Jun; 247(2):414-9. PubMed ID: 9642142
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kringle 5 of plasminogen is a novel inhibitor of endothelial cell growth.
    Cao Y; Chen A; An SS; Ji RW; Davidson D; Llinás M
    J Biol Chem; 1997 Sep; 272(36):22924-8. PubMed ID: 9278456
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanisms of kringle fragment of urokinase-induced vascular smooth muscle cell migration.
    Roztocil E; Nicholl SM; Davies MG
    J Surg Res; 2007 Jul; 141(1):83-90. PubMed ID: 17574041
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Kringle 1-4 of hepatocyte growth factor inhibits proliferation and migration of human microvascular endothelial cells.
    Kuba K; Matsumoto K; Ohnishi K; Shiratsuchi T; Tanaka M; Nakamura T
    Biochem Biophys Res Commun; 2000 Dec; 279(3):846-52. PubMed ID: 11162438
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vascular endothelial growth factor (VEGF)-C synergizes with basic fibroblast growth factor and VEGF in the induction of angiogenesis in vitro and alters endothelial cell extracellular proteolytic activity.
    Pepper MS; Mandriota SJ; Jeltsch M; Kumar V; Alitalo K
    J Cell Physiol; 1998 Dec; 177(3):439-52. PubMed ID: 9808152
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Binding of human urokinase-type plasminogen activator to its receptor: residues involved in species specificity and binding.
    Quax PH; Grimbergen JM; Lansink M; Bakker AH; Blatter MC; Belin D; van Hinsbergh VW; Verheijen JH
    Arterioscler Thromb Vasc Biol; 1998 May; 18(5):693-701. PubMed ID: 9598826
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of the urokinase receptor in vascular endothelial cells is stimulated by basic fibroblast growth factor.
    Mignatti P; Mazzieri R; Rifkin DB
    J Cell Biol; 1991 Jun; 113(5):1193-201. PubMed ID: 1645739
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Down-regulation of vascular endothelial growth factor and up-regulation of pigment epithelium-derived factor: a possible mechanism for the anti-angiogenic activity of plasminogen kringle 5.
    Gao G; Li Y; Gee S; Dudley A; Fant J; Crosson C; Ma JX
    J Biol Chem; 2002 Mar; 277(11):9492-7. PubMed ID: 11782462
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tissue factor regulates plasminogen binding and activation.
    Fan Z; Larson PJ; Bognacki J; Raghunath PN; Tomaszewski JE; Kuo A; Canziani G; Chaiken I; Cines DB; Higazi AA
    Blood; 1998 Mar; 91(6):1987-98. PubMed ID: 9490681
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apolipoprotein(a) inhibits in vitro tube formation in endothelial cells: identification of roles for Kringle V and the plasminogen activation system.
    Liu L; Boffa MB; Koschinsky ML
    PLoS One; 2013; 8(1):e52287. PubMed ID: 23326327
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Soluble tissue actor interferes with angiostatin-mediated inhibition of endothelial cell proliferation by lysine-specific interaction with plasminogen kringle domains.
    Albrecht S; Magdolen V; Herzog U; Miles L; Kirschenhofer A; Baretton G; Luther T
    Thromb Haemost; 2002 Dec; 88(6):1054-9. PubMed ID: 12529759
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Angiostatin selectively inhibits signaling by hepatocyte growth factor in endothelial and smooth muscle cells.
    Wajih N; Sane DC
    Blood; 2003 Mar; 101(5):1857-63. PubMed ID: 12406896
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NAB2, a corepressor of EGR-1, inhibits vascular endothelial growth factor-mediated gene induction and angiogenic responses of endothelial cells.
    Lucerna M; Mechtcheriakova D; Kadl A; Schabbauer G; Schäfer R; Gruber F; Koshelnick Y; Müller HD; Issbrücker K; Clauss M; Binder BR; Hofer E
    J Biol Chem; 2003 Mar; 278(13):11433-40. PubMed ID: 12427750
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Urokinase receptor antagonists inhibit angiogenesis and primary tumor growth in syngeneic mice.
    Min HY; Doyle LV; Vitt CR; Zandonella CL; Stratton-Thomas JR; Shuman MA; Rosenberg S
    Cancer Res; 1996 May; 56(10):2428-33. PubMed ID: 8625323
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel peptide isolated from a phage display library inhibits tumor growth and metastasis by blocking the binding of vascular endothelial growth factor to its kinase domain receptor.
    Hetian L; Ping A; Shumei S; Xiaoying L; Luowen H; Jian W; Lin M; Meisheng L; Junshan Y; Chengchao S
    J Biol Chem; 2002 Nov; 277(45):43137-42. PubMed ID: 12183450
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Domain structure and interactions of recombinant urokinase-type plasminogen activator.
    Novokhatny V; Medved L; Mazar A; Marcotte P; Henkin J; Ingham K
    J Biol Chem; 1992 Feb; 267(6):3878-85. PubMed ID: 1310986
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tissue-type plasminogen activator (tPA) interacts with urokinase-type plasminogen activator (uPA) via tPA's lysine binding site. An explanation of the poor fibrin affinity of recombinant tPA/uPA chimeric molecules.
    Novokhatny V; Medved L; Lijnen HR; Ingham K
    J Biol Chem; 1995 Apr; 270(15):8680-5. PubMed ID: 7721771
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cell release of bioactive fibroblast growth factor 2 by exon 6-encoded sequence of vascular endothelial growth factor.
    Jonca F; Ortéga N; Gleizes PE; Bertrand N; Plouët J
    J Biol Chem; 1997 Sep; 272(39):24203-9. PubMed ID: 9305872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.